These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 11253113

  • 1. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H, Ohgi S, Terada T.
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [Abstract] [Full Text] [Related]

  • 2. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T, Jiang CX, Li Y, Liu X.
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [Abstract] [Full Text] [Related]

  • 3. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.
    Marečko I, Cvejić D, Tatić S, Dragutinović V, Paunović I, Savin S.
    Cancer Biomark; 2009 Dec; 11(1):49-58. PubMed ID: 22820140
    [Abstract] [Full Text] [Related]

  • 4. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 5. [Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor].
    Delektorskaia VV, Smirnova EA, Ponomareva MV, Pavlova TV, Pavlov IA.
    Arkh Patol; 2010 Oct; 72(4):3-6. PubMed ID: 21086628
    [Abstract] [Full Text] [Related]

  • 6. Imbalance between Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Promotes Invasion and Metastasis of Head and Neck Squamous Cell Carcinoma.
    Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Popescu CR, Gheorghe DC.
    Clin Lab; 2017 Oct 01; 63(10):1613-1620. PubMed ID: 29035450
    [Abstract] [Full Text] [Related]

  • 7. The balance between MMP-2/-9 and TIMP-1/-2 is shifted towards MMP in renal cell carcinomas and can be further disturbed by hydrogen peroxide.
    Hemmerlein B, Johanns U, Halbfass J, Böttcher T, Heuser M, Radzun HJ, Thelen P.
    Int J Oncol; 2004 May 01; 24(5):1069-76. PubMed ID: 15067327
    [Abstract] [Full Text] [Related]

  • 8. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, Hwang BD, Yoon WH.
    BMC Cancer; 2006 Aug 18; 6():211. PubMed ID: 16916471
    [Abstract] [Full Text] [Related]

  • 9. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
    Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Daraï E.
    Int J Gynecol Cancer; 2006 Aug 18; 16(5):1911-7. PubMed ID: 17009991
    [Abstract] [Full Text] [Related]

  • 10. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
    Furuya M, Ishikura H, Kawarada Y, Ogawa Y, Sakuragi N, Fujimoto S, Yoshiki T.
    Gynecol Oncol; 2000 Aug 18; 78(2):106-12. PubMed ID: 10926788
    [Abstract] [Full Text] [Related]

  • 11. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y.
    Cancer Res; 1999 Jan 15; 59(2):467-73. PubMed ID: 9927064
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
    Jobim FC, Xavier NL, Uchoa DM, Cruz DB, Saciloto M, Chemello N, Schwartsmann G.
    Braz J Med Biol Res; 2009 Oct 15; 42(10):979-87. PubMed ID: 19787153
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
    Ondruschka C, Buhtz P, Motsch C, Freigang B, Schneider-Stock R, Roessner A, Boltze C.
    Pathol Res Pract; 2002 Oct 15; 198(8):509-15. PubMed ID: 12389993
    [Abstract] [Full Text] [Related]

  • 14. Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs.
    Mandara MT, Reginato A, Foiani G, De Luca S, Guelfi G.
    J Vet Intern Med; 2017 Nov 15; 31(6):1816-1821. PubMed ID: 28875568
    [Abstract] [Full Text] [Related]

  • 15. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 15; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

  • 16. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S, Li L, Lin JY, Lin H.
    World J Gastroenterol; 2003 May 15; 9(5):899-904. PubMed ID: 12717827
    [Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T.
    Br J Cancer; 1998 Jun 15; 77(12):2239-45. PubMed ID: 9649139
    [Abstract] [Full Text] [Related]

  • 18. Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma.
    Shi Y, Parhar RS, Zou M, Hammami MM, Akhtar M, Lum ZP, Farid NR, Al-Sedairy ST, Paterson MC.
    Br J Cancer; 1999 Mar 15; 79(7-8):1234-9. PubMed ID: 10098765
    [Abstract] [Full Text] [Related]

  • 19. [The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma].
    Chen Y, Tian K, Geng N, Yang MZ, Zhang WP.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan 15; 40(1):58-61. PubMed ID: 15774155
    [Abstract] [Full Text] [Related]

  • 20. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
    Yang HK, Jeong KC, Kim YK, Jung ST.
    Clin Orthop Surg; 2014 Dec 15; 6(4):443-54. PubMed ID: 25436070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.